{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:01:27Z","timestamp":1793037687931,"version":"4.5.0"},"reference-count":19,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2022,4,23]],"date-time":"2022-04-23T00:00:00Z","timestamp":1650672000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,8,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>Stereotactic body radiotherapy is used to treat spinal metastases; however, 10% of patients experience local failure. We aimed to clarify the outcomes of the second course of stereotactic body radiotherapy for spinal metastases with a uniform fractionation schedule at our institution.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Data of patients treated with a second salvage stereotactic body radiotherapy course at the same spinal level or adjacent level from July 2018 to December 2020 were retrospectively reviewed. The initial prescribed dose was 24\u00a0Gy in two fractions, and the second dose 30 or 35\u00a0Gy in five fractions. The spinal cord dose constraint at the second course was 15.5\u00a0Gy at the maximum point dose. The endpoints were local failure and adverse effects. Local failure was defined as tumor progression using imaging.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>We assessed 19 lesions in 17 patients, with radioresistant lesions in 14 (74%) cases, the second stereotactic body radiotherapy to the same\/adjacent spinal level in 13\/6 cases, the median interval between stereotactic body radiotherapy of 23 (range, 6\u201352) months, and lesions compressing the cord in 5 (26%) cases. The median follow-up period was 19\u00a0months. The 12- and 18-month local failure rates were 0% and 8%, respectively. Radiation-induced myelopathy, radiculopathy and vertebral compression fractures were observed in 0 (0%), 4 (21%) and 2 (11%) lesions, respectively. Three patients with radiculopathy experienced almost complete upper or lower limb paralysis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>The second course of salvage stereotactic body radiotherapy for spinal metastases achieved good local control with a reduced risk of myelopathy. However, a high occurrence rate of radiation-induced radiculopathy has been confirmed.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jjco\/hyac070","type":"journal-article","created":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T11:18:22Z","timestamp":1649935102000},"page":"911-916","source":"Crossref","is-referenced-by-count":12,"title":["Risk of radiculopathy caused by second course of spine stereotactic body radiotherapy"],"prefix":"10.1093","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5792-3795","authenticated-orcid":false,"given":"Kei","family":"Ito","sequence":"first","affiliation":[{"name":"Division of Radiation Oncology , Department of Radiology, , Bunkyo-ku, Tokyo, Japan"},{"name":"Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital , Department of Radiology, , Bunkyo-ku, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujiro","family":"Nakajima","sequence":"additional","affiliation":[{"name":"Division of Radiation Oncology , Department of Radiology, , Bunkyo-ku, Tokyo, Japan"},{"name":"Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital , Department of Radiology, , Bunkyo-ku, Tokyo, Japan"},{"name":"Department of Radiological Sciences, Komazawa University , Setagaya-ku, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Ogawa","sequence":"additional","affiliation":[{"name":"Division of Radiation Oncology , Department of Radiology, , Bunkyo-ku, Tokyo, Japan"},{"name":"Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital , Department of Radiology, , Bunkyo-ku, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Taguchi","sequence":"additional","affiliation":[{"name":"Division of Radiation Oncology , Department of Radiology, , Bunkyo-ku, Tokyo, Japan"},{"name":"Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital , Department of Radiology, , Bunkyo-ku, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shurei","family":"Sugita","sequence":"additional","affiliation":[{"name":"Department of Orthopedic surgery, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital , Bunkyo-ku, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,4,23]]},"reference":[{"key":"2022093018320266200_ref1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.prro.2016.08.001","article-title":"Palliative radiation therapy for bone metastases: update of an ASTRO evidence-based guideline","volume":"7","author":"Lutz","year":"2017","journal-title":"Pract Radiat Oncol"},{"key":"2022093018320266200_ref2","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3171\/2017.1.SPINE16684","article-title":"Stereotactic body radiotherapy for de novo spinal metastases: systematic review","volume":"27","author":"Husain","year":"2017","journal-title":"J Neurosurg Spine"},{"key":"2022093018320266200_ref3","doi-asserted-by":"crossref","first-page":"E6","DOI":"10.3171\/2016.9.FOCUS16369","article-title":"The impact of histology and delivered dose on local control of spinal metastases treated with stereotactic radiosurgery","volume":"42","author":"Yamada","year":"2017","journal-title":"Neurosurg Focus"},{"key":"2022093018320266200_ref4","doi-asserted-by":"crossref","first-page":"428","DOI":"10.3171\/2017.2.SPINE16976","article-title":"Reirradiation spine stereotactic body radiation therapy for spinal metastases: systematic review","volume":"27","author":"Myrehaug","year":"2017","journal-title":"J Neurosurg Spine"},{"key":"2022093018320266200_ref5","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S1470-2045(21)00196-0","article-title":"Stereotactic body radiotherapy versus conventional external beam radiotherapy in patients with painful spinal metastases: an open-label, multicentre, randomised, controlled, phase 2\/3 trial","volume":"22","author":"Sahgal","year":"2021","journal-title":"Lancet Oncol"},{"key":"2022093018320266200_ref6","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ijrobp.2021.07.1690","article-title":"Phase 2 clinical trial of separation surgery followed by stereotactic body radiation therapy for metastatic epidural spinal cord compression","volume":"112","author":"Ito","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2022093018320266200_ref7","doi-asserted-by":"crossref","first-page":"e597","DOI":"10.1016\/j.ijrobp.2012.03.009","article-title":"International spine radiosurgery consortium consensus guidelines for target volume definition in spinal stereotactic radiosurgery","volume":"83","author":"Cox","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2022093018320266200_ref8","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ijrobp.2016.09.014","article-title":"Consensus contouring guidelines for postoperative stereotactic body radiation therapy for metastatic solid tumor malignancies to the spine","volume":"97","author":"Redmond","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2022093018320266200_ref9","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ijrobp.2010.08.021","article-title":"Reirradiation human spinal cord tolerance for stereotactic body radiotherapy","volume":"82","author":"Sahgal","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2022093018320266200_ref10","doi-asserted-by":"crossref","first-page":"e595","DOI":"10.1016\/S1470-2045(15)00166-7","article-title":"Response assessment after stereotactic body radiotherapy for spinal metastasis: a report from the SPIne response assessment in neuro-oncology (SPINO) group","volume":"16","author":"Thibault","year":"2015","journal-title":"Lancet Oncol"},{"key":"2022093018320266200_ref11","author":"US Department of Health and Human Services Common Terminology Criteria for Adverse Events (CTCAE)"},{"key":"2022093018320266200_ref12","first-page":"1576","article-title":"Radiation-induced myelitis: initial and follow-up MRI and clinical features in patients at a single tertiary care institution during 20 years","volume":"39","author":"Khan","year":"2018","journal-title":"AJNR Am J Neuroradiol"},{"key":"2022093018320266200_ref13","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/0360-3016(95)00060-C","article-title":"Toxicity criteria of the radiation therapy oncology group (RTOG) and the European Organization for Research and Treatment of cancer (EORTC)","volume":"31","author":"Cox","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2022093018320266200_ref14","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u201cEZR\u201d for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"2022093018320266200_ref15","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ijrobp.2012.05.007","article-title":"Probabilities of radiation myelopathy specific to stereotactic body radiation therapy to guide safe practice","volume":"85","author":"Sahgal","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2022093018320266200_ref16","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3171\/2010.3.SPINE09459","article-title":"Reliability analysis of the epidural spinal cord compression scale","volume":"13","author":"Bilsky","year":"2010","journal-title":"J Neurosurg Spine"},{"key":"2022093018320266200_ref17","doi-asserted-by":"crossref","first-page":"E12","DOI":"10.3171\/2016.11.FOCUS16348","article-title":"Peripheral nervous system injury after high-dose single-fraction image-guided stereotactic radiosurgery for spine tumors","volume":"42","author":"Stubblefield","year":"2017","journal-title":"Neurosurg Focus"},{"key":"2022093018320266200_ref18","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1093\/jjco\/hyaa178","article-title":"Efficacy and toxicity of re-irradiation spine stereotactic body radiotherapy with respect to irradiation dose history","volume":"51","author":"Ito","year":"2021","journal-title":"Jpn J Clin Oncol"},{"key":"2022093018320266200_ref19","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ijrobp.2015.03.029","article-title":"Salvage stereotactic body radiotherapy (SBRT) following in-field failure of initial SBRT for spinal metastases","volume":"93","author":"Thibault","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Japanese Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jjco\/article-pdf\/52\/8\/911\/46214327\/hyac070.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jjco\/article-pdf\/52\/8\/911\/46214327\/hyac070.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T19:47:54Z","timestamp":1664567274000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jjco\/article\/52\/8\/911\/6573314"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,23]]},"references-count":19,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2022,4,23]]},"published-print":{"date-parts":[[2022,8,5]]}},"URL":"https:\/\/doi.org\/10.1093\/jjco\/hyac070","relation":{},"ISSN":["1465-3621"],"issn-type":[{"value":"1465-3621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,8]]},"published":{"date-parts":[[2022,4,23]]}}}